Our data indicate that CRIF1 inhibits HCC cell proliferation, decreases the percentage of G1 phase cells, and inhibits in vivo tumorigenicity of HCC xenografts. This evidence concerns the gene GADD45GIP1 and hepatocellular carcinoma.